PTC TherapeuticsPTCT was a big mover last session, as its shares rose over 15% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This also led to far more shares changing hands than in a normal session. Yesterday's rally reverses the downtrend of the company since Feb 22, as the stock is now down over 78%.
Over the last 7 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday's jump can turn into more strength down the road.
PTC Therapeutics currently has a Zacks Rank #2 (Buy).
Another favorably ranked med-drugs stock is Auris Medical Holding AG EARS with a Zacks Rank #1 (Strong Buy).